Subscribe now

Analysis and Health

Will waiving patents for covid-19 vaccines boost global supplies?

By Adam Vaughan

10 May 2021 Last updated 10 May 2021

A medical worker transfers a dose of covid-19 vaccine at the Makati Coliseum in the Philippines

A medical worker transfers a dose of covid-19 vaccine at the Makati Coliseum in the Philippines

Credit: Majority World/Shutterstock

“These extraordinary times and circumstances… call for extraordinary measures,” tweeted US trade representative Katherine Tai, as she surprised the world by throwing the country’s backing behind a temporary waiver of intellectual property rights for covid-19 vaccines.

The announcement on 5 May turbo-charged an idea pushed by India, South Africa and many campaigners: that lifting the IP protections on covid-19 vaccines would boost supplies by allowing the vaccines to be made in greater numbers, in more countries.

Tedros Adhanom Ghebreyesus, director…

Article amended on 10 May 2021

This article has been updated to include information on the World Health Organization's C-TAP plan.  

Sign up to our weekly newsletter

Receive a weekly dose of discovery in your inbox. We'll also keep you up to date with New Scientist events and special offers.

Sign up

To continue reading, subscribe today with our introductory offers

Piano Exit Overlay Banner Mobile Piano Exit Overlay Banner Desktop